JT
COGT icon

Jupiter Topco’s Cogent Biosciences COGT Stock Holding History

Jupiter Topco’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256M Buy
+6,624,848
New +$232M 0.1% 183

Other funds holding COGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Jupiter Topco's COGT Position: Q2 2026 in Review

Jupiter Topco opened a new position in Cogent Biosciences (COGT) in Q2 2026: 6,624,848 shares worth $256M. The stake represents 0.1% of the portfolio and ranks #183 among its holdings.

290 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Jupiter Topco held 6,624,848 shares of Cogent Biosciences worth $256M as of Q2 2026.
  • Cogent Biosciences was a new Jupiter Topco position in Q2 2026.
  • Cogent Biosciences made up 0.1% of Jupiter Topco's portfolio in Q2 2026, its #183 holding.
  • 290 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.